400
Participants
Start Date
April 30, 1997
Primary Completion Date
March 31, 2004
Study Completion Date
March 31, 2004
filgrastim
CHOP regimen
cyclophosphamide
cytarabine
doxorubicin hydrochloride
etoposide
leucovorin calcium
melphalan
methotrexate
methylprednisolone
mitoxantrone hydrochloride
prednisone
therapeutic hydrocortisone
vincristine sulfate
bone marrow ablation with stem cell support
peripheral blood stem cell transplantation
radiation therapy
Centre Hospitalier Universitaire Vaudois, Lausanne
Saint Savvas Cancer Hospital of Athens, Athens
European Institute of Oncology, Milan
Allgemeines Krankenhaus der Stadt Wien, Vienna
Dr. Horst-Schmidt-Kliniken, Wiesbaden
Universitatsspital-Basel, Basel
Oncology Institute of Southern Switzerland, Bellinzona
Inselspital, Bern, Bern
Ratisches Kantons und Regionalspital, Chur
Hopital Cantonal Universitaire de Geneve, Collonge-Bellerive
Kantonsspital - St. Gallen, Sankt Gallen
Klinik Hirslanden, Zurich
Swiss Cancer Institute
OTHER